Clinical trial
Combination Chemotherapy in Treating Patients With Recurrent or Metastatic…
NCT00003287 · European Organisation for Research and Treatment of Cancer - EORTC, Other · Completed
Key facts
| NCT number | NCT00003287 |
|---|---|
| Title | Combination Chemotherapy in Treating Patients With Recurrent or Metastatic Colorectal Cancer |
| Official title | First Line Infusional 5-Fluorouracil, Folinic Acid and Oxaliplatin for Metastatic Colorectal Cancer or Loco-Regional Recurrency - Role of Chronomodulated Delivery Upon Survival - A Multicenter Randomized Phase III Trial |
| Lead sponsor | European Organisation for Research and Treatment of Cancer - EORTC, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Colorectal Cancer |
| Intervention type | Drug |
| Interventions | FOLFOX regimen, fluorouracil, leucovorin calcium, oxaliplatin |
| Enrollment | 554 |
| Start date | Mar 1, 1998 |
| Primary completion | Mar 1, 2002 |
| First posted | Jan 23, 2004 |
| Last update posted | Jul 2, 2012 |
| Countries | Austria, Belgium, Canada, France, Germany, Greece, Italy, Norway, Portugal |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: